Public Employees Retirement System Of Ohio Aadi Bioscience, Inc. Transaction History

Public Employees Retirement System Of Ohio

$22.6 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.46 - $2.31 $83 - $131	-57 Reduced 5.7%	943 $1,000
Q1 2024 May 15, 2024	SELL	$1.59 - $2.44 $10,812 - $16,592	-6,800 Reduced 87.18%	1,000 $2,000
Q4 2023 Feb 15, 2024	BUY	$1.97 - $5.41 $12,214 - $33,542	6,200 Added 387.5%	7,800 $15,000
Q3 2023 Nov 15, 2023	BUY	$4.84 - $7.13 $7,744 - $11,408	1,600 New	1,600 $8,000

Others Institutions Holding AADI

# of Institutions

Shares Held

12.6M

Call Options Held

23.8K

Put Options Held

Avoro Capital Advisors LLC New York, NY

2.85M
Shares

$6.55 Million
0.09% of portfolio
Bml Capital Management, LLC Zionsville, IN

2M
Shares

$4.6 Million
2.42% of portfolio
Acuta Capital Partners, LLC Belmont, CA

1.85M
Shares

$4.25 Million
3.86% of portfolio
Eco R1 Capital, LLC San Francisco, CA

1.85M
Shares

$4.24 Million
0.16% of portfolio
Vanguard Group Inc Valley Forge, PA

766K
Shares

$1.76 Million
0.0% of portfolio

View Full List

About Aadi Bioscience, Inc.

Ticker AADI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,016,800
Market Cap $48.3M
Description
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...

More about AADI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.

Account